2 doses of vaccine Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Human Papillomavirus (HPV) Infection

Drug Information

Target Indication

Human Papillomavirus (HPV) Infection

Clinical Trial

Last updated: 6/26/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

VCNX

Vaccinex, Inc.

Related Pipeline

HPV InfectioN

Norovirus Infections

Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)

Huntington's Disease

Alzheimer Disease

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts